Colgate-Palmolive (CL) – Analysts’ Weekly Ratings Changes

Several brokerages have updated their recommendations and price targets on shares of Colgate-Palmolive (NYSE: CL) in the last few weeks:

• 11/4/2025 – Colgate-Palmolive had its price target lowered by analysts at Barclays PLC from $82.00 to $80.00. They now have an “equal weight” rating on the stock.
• 11/3/2025 – Colgate-Palmolive had its price target lowered by analysts at Evercore ISI from $100.00 to $94.00. They now have an “outperform” rating on the stock.
• 11/3/2025 – Colgate-Palmolive had its price target lowered by analysts at Morgan Stanley from $96.00 to $87.00. They now have an “overweight” rating on the stock.
• 11/3/2025 – Colgate-Palmolive had its price target lowered by analysts at Citigroup Inc. from $105.00 to $95.00. They now have a “buy” rating on the stock.
• 11/3/2025 – Colgate-Palmolive had its price target lowered by analysts at UBS Group AG from $92.00 to $90.00. They now have a “buy” rating on the stock.
• 11/3/2025 – Colgate-Palmolive had its price target lowered by analysts at JPMorgan Chase & Co. from $88.00 to $87.00. They now have an “overweight” rating on the stock.
• 11/3/2025 – Colgate-Palmolive had its price target lowered by analysts at Wells Fargo & Company from $80.00 to $77.00. They now have an “underweight” rating on the stock.
• 10/20/2025 – Colgate-Palmolive had its price target lowered by analysts at Raymond James Financial, Inc. from $105.00 to $95.00. They now have an “outperform” rating on the stock.
• 10/10/2025 – Colgate-Palmolive was given a new $86.00 price target on by analysts at Deutsche Bank Aktiengesellschaft.
• 10/10/2025 – Colgate-Palmolive had its price target lowered by analysts at JPMorgan Chase & Co. from $95.00 to $88.00. They now have an “overweight” rating on the stock.
• 10/8/2025 – Colgate-Palmolive had its price target lowered by analysts at UBS Group AG from $99.00 to $92.00. They now have a “buy” rating on the stock.
• 10/8/2025 – Colgate-Palmolive had its price target lowered by analysts at Bank of America Corporation from $98.00 to $88.00. They now have a “buy” rating on the stock.
• 10/8/2025 – Colgate-Palmolive had its “hold (c)” rating reaffirmed by analysts at Weiss Ratings.
• 10/3/2025 – Colgate-Palmolive is now covered by analysts at Piper Sandler. They set a “neutral” rating and a $84.00 price target on the stock.
• 10/2/2025 – Colgate-Palmolive had its price target lowered by analysts at The Goldman Sachs Group, Inc. from $106.00 to $91.00. They now have a “buy” rating on the stock.
• 10/1/2025 – Colgate-Palmolive had its price target lowered by analysts at Barclays PLC from $87.00 to $82.00. They now have an “equal weight” rating on the stock.
• 9/27/2025 – Colgate-Palmolive had its “hold (c)” rating reaffirmed by analysts at Weiss Ratings.
• 9/25/2025 – Colgate-Palmolive had its price target lowered by analysts at Wells Fargo & Company from $83.00 to $80.00. They now have an “underweight” rating on the stock.

Colgate-Palmolive Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Friday, November 14th. Shareholders of record on Friday, October 17th were paid a dividend of $0.52 per share. The ex-dividend date of this dividend was Friday, October 17th. This represents a $2.08 annualized dividend and a yield of 2.6%. Colgate-Palmolive’s dividend payout ratio (DPR) is presently 58.26%.

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.